Charles Schwab’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.9M | Sell |
1,600,693
-329,775
| -17% | -$12.1M | 0.01% | 999 |
|
|
2025
Q1 | $68.3M | Sell |
1,930,468
-646
| -0% | -$22.8K | 0.01% | 858 |
|
|
2024
Q4 | $84.5M | Buy |
1,931,114
+167,997
| +10% | +$7.35M | 0.02% | 757 |
|
|
2024
Q3 | $80M | Buy |
1,763,117
+653,433
| +59% | +$29.6M | 0.02% | 796 |
|
|
2024
Q2 | $43.1M | Buy |
1,109,684
+57,421
| +5% | +$2.23M | 0.01% | 1187 |
|
|
2024
Q1 | $33.9M | Buy |
1,052,263
+9,296
| +0.9% | +$300K | 0.01% | 1276 |
|
|
2023
Q4 | $29.9M | Buy |
1,042,967
+276,298
| +36% | +$7.92M | 0.01% | 1332 |
|
|
2023
Q3 | $21.2M | Buy |
766,669
+55,558
| +8% | +$1.54M | 0.01% | 1472 |
|
|
2023
Q2 | $19M | Buy |
711,111
+53,884
| +8% | +$1.44M | 0.01% | 1539 |
|
|
2023
Q1 | $14.2M | Buy |
657,227
+94,140
| +17% | +$2.04M | ﹤0.01% | 1697 |
|
|
2022
Q4 | $13.4M | Buy |
563,087
+22,715
| +4% | +$541K | ﹤0.01% | 1684 |
|
|
2022
Q3 | $10.7M | Buy |
540,372
+95,969
| +22% | +$1.89M | ﹤0.01% | 1793 |
|
|
2022
Q2 | $8.66M | Buy |
444,403
+191
| +0% | +$3.72K | ﹤0.01% | 1915 |
|
|
2022
Q1 | $11.3M | Buy |
444,212
+13,134
| +3% | +$335K | ﹤0.01% | 1884 |
|
|
2021
Q4 | $10.9M | Buy |
431,078
+5,238
| +1% | +$132K | ﹤0.01% | 1958 |
|
|
2021
Q3 | $11.7M | Buy |
425,840
+70,898
| +20% | +$1.95M | ﹤0.01% | 1911 |
|
|
2021
Q2 | $11.3M | Buy |
354,942
+40,136
| +13% | +$1.27M | ﹤0.01% | 1931 |
|
|
2021
Q1 | $14.4M | Buy |
314,806
+47,735
| +18% | +$2.19M | 0.01% | 1748 |
|
|
2020
Q4 | $10.6M | Buy |
267,071
+2,532
| +1% | +$100K | ﹤0.01% | 1836 |
|
|
2020
Q3 | $9.21M | Buy |
264,539
+167,008
| +171% | +$5.81M | ﹤0.01% | 1752 |
|
|
2020
Q2 | $3.08M | Buy |
97,531
+67,650
| +226% | +$2.14M | ﹤0.01% | 2266 |
|
|
2020
Q1 | $655K | Buy |
+29,881
| New | +$655K | ﹤0.01% | 2616 |
|